Article
A multiparametric approach to monitor the effects of γ-secretase inhibition along the whole intestinal tract.
Disease models & mechanisms - 1 Jan 2012
Droy-Dupré Laure, Vallée Mickaël, Bossard Céline, Laboisse Christian L, Jarry Anne
Abstract excerpt
γ-secretase inhibitors (GSIs) have been recently proposed as chemopreventive agents in gastrointestinal neoplasia, because they lead, through inhibition of the Notch signaling pathway, to goblet cell conversion in some intestinal adenomas of the Apc(Min) mice, and halt epithelial cell proliferation. In this study, we examine in depth, in normal mice, the effects of a GSI, dibenzazepine (DBZ), intraperitoneally...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
